The 36th Annual Congress of the European Association of Nuclear Medicine (EANM) #EANM23 was held this year in Vienna from 9 to 13 September. It is a world-reference congress in nuclear medicine gathering clinical scientists, technologists, physicians, industry representatives and researchers.
Springer Healthcare IME hosted a symposium entitled “Preparing for the new era of neuroimaging for Alzheimer’s disease” on 10 September. The symposium was supported by an educational grant from Lilly and moderated by the AMYPAD Project Coordinator Frederik Barkhof (Amsterdam UMC,The Netherlands and University College London, UK). The learning objectives of the symposium were to:
The programme of the symposium included three talks:
During their respective presentations, Lyduine and Alexander shared some AMYPAD results.
For more information about #EANM23, visit https://eanm23.eanm.org/
We look forward to seeing you all at the #EANM24 in Hamburg, on October 19-23, 2024.